该产品是授权默克制药公司于2005年。

This product was licensed from Merck, KGaA in 2005.

youdao

默克制药（MRK）收购Schering-Plough（先灵葆雅），希望到2013年在新兴市场的由目前的18%上升至25%。

Since it purchased Schering-Plough, Merck has wanted to increase its sales in emerging markets from 18% to 25% by 2013.

youdao

去年下旬，默克制药公司透露其正面临与美国及加拿大税务部门的四起纠纷，这可能要使它耗资56亿美元来支付那些多余税收和利息的费用。

Late last year Merck, a drugs company, disclosed that it is facing four disputes with American and Canadian tax authorities that could cost it $5.6 billion in additional taxes and interest.

youdao